EARLY CLOSURE MARCH 4 - Due to the forecast for severe winter weather, Creighton's Omaha campus will close at 7 P.M. this evening.
All in-person classes, clinics, and events, regardless of start time, are asked to end by 7 P.M. For those needing a shuttle, please visit my.creighton.edu for the most up-to-date maps and schedule. Shuttles will run until 8 P.M. this evening. We encourage you to be mindful of other closures or impacted services across the city as well.
Employees, including those classified as responsible for “essential operations” should review Creighton's Weather and Emergency-Related Absence Policy and work with your immediate supervisor on expectations for job functions during this curtailment of campus operations.
Please be take proper winter weather precautions throughout the day and contact public safety at 402.280.2911 for any emergencies.
Board Certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine
Areas of Interest: Interstitial lung disease, pulmonary nodules/lung cancer, critical care medicine
Pulmonary and Critical Care Medicine Fellowship: Creighton University School of Medicine, Omaha, NE
Residency: Creighton University School of Medicine, Omaha, NE
Medical School: Creighton University School of Medicine, Omaha, NE
Medicine
Associate Professor
Role: Sub-investigator
Source: Forest/AstraZenaca
Type: Industry-sponsored, multicenter trial
Title: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Phase IV Study to Evaluate the Effect of Aclidinium Bromide on Long-Term Cardiovascular Safety and COPD Exacerbations in Patients With Moderate to Very Severe COPD (ASCENT COPD), Protocol #LAS-MD-45
Dates: 11/15/2013-12/2017